<i>NRG1</i> fusions in solid tumors.
Brinda Gupta(Georgetown University), Stephen V. Liu(Georgetown University), Kathryn F. Mileham(Levine Cancer Institute), Ari M. Vanderwalde(West Cancer Center), Sharon Wu(Caris Life Sciences (United States)), Benjamin A. Weinberg(Georgetown University), Hossein Borghaei(Fox Chase Cancer Center), Misako Nagasaka(University of California, Irvine), Nishant Gandhi(Caris Life Sciences (United States)), George W. Sledge(Caris Life Sciences (United States)), Sourat Darabi(Hoag Memorial Hospital Presbyterian), Wafik S. El‐Deiry(Brown University), Sai‐Hong Ignatius Ou(University of California, Irvine Medical Center), C. Patrick(Penn State Milton S. Hershey Medical Center), Alex Farrell(Caris Life Sciences (United States))
Cited by 7
Related Papers
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.5k
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
|Cell Death and Differentiation|2008|3.3k
Alectinib versus Crizotinib in Untreated <i>ALK</i>-Positive Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2017|2.4k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k